Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2013 | 09-2012 | 09-2011 | 09-2010 | 09-2009 | |
| Sales | 290 | 147 | 296 | 0 | 3,758 |
| Gross Profit | 290 | 147 | 296 | N/A | 3,758 |
| Operating Expenses | 24,880 | 21,236 | 10,126 | 5,833 | 23,318 |
| Operating Income | -24,589 | -21,089 | -9,830 | -5,833 | -19,560 |
| Other Income | -7,114 | -1,021 | 1,045 | 1,521 | 416 |
| Pre-tax Income | -31,703 | -22,111 | -8,785 | -4,312 | -19,145 |
| Net Income Continuous | -31,703 | -22,111 | -8,785 | -4,312 | -19,145 |
| Net Income Discontinuous | 0 | 0 | 5,293 | -2,645 | -164 |
| Minority Interests | -560 | -985 | -364 | -1,183 | 0 |
| Net Income | $-31,143 | $-21,126 | $-3,129 | $-5,774 | $-19,308 |
| EPS Basic Total Ops | -1.30 | -1.90 | -0.44 | -0.90 | -4.30 |
| EPS Basic Continuous Ops | -1.32 | -1.90 | -1.18 | -0.49 | -4.30 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.74 | -0.41 | -0.04 |
| EPS Diluted Total Ops | -1.30 | -1.90 | -0.44 | -0.90 | -4.30 |
| EPS Diluted Continuous Ops | -1.32 | -1.90 | -1.18 | -0.49 | -4.30 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.74 | -0.41 | -0.04 |
| EBITDA(a) | $-22,710 | $-19,331 | $-9,570 | $-5,555 | $-18,565 |